GWLL Goldenwell Biotech, Inc.
Fundamentals / CIK 0001800373 / USDGoldenwell Biotech, Inc. reported $55 in revenue and a net loss of $286K for the trailing twelve months ended September 30, 2026 (down 60.4% year over year), with a 21.8% gross margin and a -215356.4% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GWLL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$55 -60.4% YoY
-
Operating Income TTM-$118K -215356.4% margin
-
Net Income TTM-$286K -519567.3% net margin
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: --
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $55 | $139 | $1.8K | $48K | $16K | $0 | $0 |
| Cost of Revenue | $43 | $75 | $1.2K | $23K | $7.6K | $0 | $0 |
| Gross Profit | $12 | $64 | $666 | $25K | $8.4K | $0 | $0 |
| Selling, General & Admin | -- | -- | -- | -- | $127K | $6.4K | $2.6K |
| Total Operating Expenses | $113K | $123K | $116K | $1.01M | -$127K | $6.4K | $2.6K |
| Operating Income | -$113K | -$123K | -$116K | -$985K | -$118K | -$6.4K | -$2.6K |
| Interest Expense | $8.4K | $8.4K | $1.5K | -- | $0 | $0 | $0 |
| Income Before Tax | -- | -$131K | -$117K | -- | -$118K | -$6.4K | -$2.6K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$296K | -$131K | -$117K | -$985K | -$117K | -$6.3K | -$2.3K |
| Basic EPS | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | 91.3M | 80.0M | 76.2M |
| Diluted Shares Outstanding | 99.0M | 99.0M | 99.0M | -- | 91.3M | 80.0M | 76.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $55 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $43 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $12 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $29K | $35K | $31K | $23K | $26K | $28K | $36K | $25K |
| Operating Income | -$29K | -$35K | -$31K | -$23K | -$26K | -$28K | -$36K | -$25K |
| Interest Expense | -- | -- | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -$34K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$32K | -$37K | -$18K | -$200K | -$28K | -$30K | -$39K | -$27K |
| Diluted EPS | -- | $0.00 | $0.00 | $0.00 | -- | -- | $0.00 | $0.00 |
| Diluted Shares Outstanding | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M | 99.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | -- | $53K | $46K | $214K | $249K | $247K |
| Cash & Short-Term Investments | -- | -- | $53K | $46K | $214K | $249K | $247K |
| Accounts Receivable, Net | -- | $0 | $0 | $0 | $0 | -- | -- |
| Inventory | $175K | $175K | $175K | $176K | $199K | $0 | -- |
| Total Current Assets | -- | -- | -- | -- | -- | -- | $247K |
| Intangible Assets | -- | -- | -- | -- | -- | $0 | $0 |
| Total Non-Current Assets | -- | -- | -- | -- | -- | -- | $0 |
| Total Assets | $36K | $224K | $228K | $248K | $461K | $249K | $247K |
| Accounts Payable | $0 | $0 | $0 | $0 | $111K | $0 | -- |
| Deferred Revenue (Current) | $1.9K | $0 | -- | -- | -- | -- | -- |
| Total Current Liabilities | $102K | $1.9K | -- | -- | $159K | $0 | $0 |
| Long-Term Debt | -- | $174K | $46K | -- | -- | -- | -- |
| Other Non-Current Liabilities | $189K | $189K | $70K | -- | -- | -- | -- |
| Total Non-Current Liabilities | $323K | $270K | -- | $20K | $0 | $0 | $0 |
| Total Liabilities | $425K | $271K | $144K | $47K | $159K | $0 | $0 |
| Total Debt (incl. Leases) | -- | $174K | $46K | $25K | $48K | -- | -- |
| Common Stock | $9.9K | $9.9K | $9.9K | $9.9K | $9.6K | $9.2K | $8.0K |
| Retained Earnings | -$1.66M | -$1.36M | -$1.23M | -$1.11M | -$126K | -$8.6K | -$2.3K |
| Total Stockholders' Equity | -$344K | -$47K | $84K | $202K | $302K | $249K | $247K |
| Total Equity | -$344K | -$47K | $84K | $202K | $302K | $249K | $247K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Accounts Receivable, Net | -- | -- | $0 | -- | $0 | $0 | -- | $0 |
| Inventory | -- | $0 | $0 | $175K | $175K | $175K | $175K | $175K |
| Total Assets | $15K | $29K | $19K | $36K | $220K | $251K | $192K | $224K |
| Accounts Payable | -- | $0 | $0 | $0 | $0 | $0 | -- | $0 |
| Deferred Revenue (Current) | -- | $0 | $100K | $1.9K | $38K | $62K | -- | $0 |
| Total Current Liabilities | $100K | $100K | $100K | $102K | $39K | $64K | -- | $1.9K |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $176K | $174K |
| Other Non-Current Liabilities | $189K | $189K | $189K | $189K | $189K | $189K | $189K | $189K |
| Total Non-Current Liabilities | $344K | $327K | $280K | $323K | $276K | $274K | -- | $270K |
| Total Liabilities | $444K | $427K | $380K | $425K | $315K | $338K | $274K | $271K |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | $176K | $174K |
| Common Stock | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K | $9.9K |
| Retained Earnings | -$1.74M | -$1.71M | -$1.67M | -$1.66M | -$1.41M | -$1.40M | -$1.39M | -$1.36M |
| Total Stockholders' Equity | -$430K | -$398K | -$361K | -$344K | -$144K | -$116K | -$86K | -$47K |
| Total Equity | -$430K | -$398K | -$361K | -$344K | -$144K | -$116K | -$86K | -$47K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$296K | -$131K | -$117K | -$985K | $117K | -$6.3K | -$2.3K |
| Change in Receivables | -- | -- | $0 | $0 | $0 | -- | -- |
| Change in Inventory | $43 | $75 | $1.2K | -$23K | -$199K | $0 | -- |
| Change in Payables | -- | -- | -- | -$111K | $111K | $0 | -- |
| Operating Cash Flow | -$23K | -$123K | -$113K | -$1.07M | -$205K | -$6.3K | -$2.3K |
| Common Stock Issued | -- | -- | $0 | $300 | $92K | $8.3K | $249K |
| Financing Cash Flow | $0 | $119K | $120K | $905K | $170K | $8.3K | $249K |
| Net Change in Cash | -$23K | -$3.8K | $7.2K | -$168K | -$35K | $2.0K | $247K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$32K | -$37K | -$18K | -$200K | -$28K | -$30K | -$39K | -$27K |
| Change in Receivables | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| Change in Inventory | $0 | $0 | $175K | $43 | $0 | $0 | $0 | -$73 |
| Change in Payables | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| Operating Cash Flow | -$25K | -$47K | -$13K | -$19K | -$31K | $59K | -$32K | -$25K |
| Common Stock Issued | -- | $0 | $0 | -- | $0 | $0 | $0 | -- |
| Financing Cash Flow | $15K | $45K | $0 | $0 | $0 | $0 | $0 | $70K |
| Net Change in Cash | -$10K | -$2.3K | -$13K | -$19K | -$31K | $59K | -$32K | $45K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 21.8% | 46.0% | 36.3% | 52.7% | 52.5% | -- | -- |
| Operating Margin | -206047.3% | -88559.7% | -6308.6% | -2060.9% | -740.7% | -- | -- |
| Net Profit Margin | -539038.2% | -94602.9% | -6392.2% | -2060.9% | -732.6% | -- | -- |
| Return on Equity (ROE) | -- | -- | -139.3% | -488.6% | -38.8% | -2.5% | -0.9% |
| Return on Assets (ROA) | -820.8% | -58.7% | -51.5% | -396.6% | -25.4% | -2.5% | -0.9% |
| Quick Ratio | -- | -- | -- | -- | 1.34x | -- | -- |
| Debt to Equity | -- | -- | 0.55x | 0.13x | 0.16x | -- | -- |
| Revenue Growth (YoY) | -60.4% | -92.4% | -96.2% | +199.4% | -- | -- | -- |
| Gross Profit Growth (YoY) | -81.2% | -90.4% | -97.4% | +200.3% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.8% | 21.8% | 21.8% | 21.8% | -- | -- | 50.4% | 50.4% |
| Operating Margin | -215356.4% | -208729.1% | -196772.7% | -206047.3% | -- | -- | -93937.4% | -88556.1% |
| Net Profit Margin | -519567.3% | -512940.0% | -500983.6% | -539038.2% | -- | -- | 5033.8% | 55043.2% |
| Return on Assets (ROA) | -1965.6% | -973.6% | -1469.2% | -820.8% | -56.3% | -29.1% | 3.6% | 34.1% |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -100.0% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -220.9% | -160.7% | -224.4% | -- |
| Operating Cash Flow Growth (YoY) | -- | -179.6% | -- | -- | -- | -- | -- | -- |